ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES

The role of sympathetic signaling in inflammation-induced colon dysfunction and recovery

Active
Institution
Mayo Clinic Rochester, MN
Principal investigator
Wilmarie Morales-Soto
Funding
$76K
Duration
2025–2028
Open portfolio

Moonbase score

Still being scored

Abstract

PROJECT SUMMARY Inflammatory bowel disease is characterized by remitting and relapsing bouts of intestinal inflammation and symptoms of abdominal pain, dysmotility, and autonomic dysfunction persist beyond the periods of active inflammation. Evidence suggests that neural pathways of the Gut-Brain Axis, particularly the sympathetic nervous system, are involved in pathophysiology, but until recently technical restrictions have limited the ability to fully understand the underlying neural circuit mechanisms. Therefore, the proposed training and research plans are focused on developing the Applicant’s expertise in sympathetic regulation of gastrointestinal function in health and disease. The training plan focuses on development of innovative technical skills and comprehensive career mentorship with the goal of providing the Applicant a complete set of skills necessary to develop into an independent scientist investigating the Gut-Brain Axis. The research plan complements this training by investigating how sensory-sympathetic neural pathways regulate the outcomes of colitis and recovery, specifically delineating the mechanisms used by two distinct circuits innervating the colon: (1) extrinsic primary afferent neuron (ExPAN)-spinal-sympathetic pathways and (2) intestinofugal afferent neuron (IFAN)-sympathetic pathways. This will be achieved through two Specific Aims utilizing innovative ex vivo imaging techniques with optogenetic reporters in intact sensory-sympathetic colon circuits, advanced in vivo chemogenetic approaches, and cutting-edge in vitro systems with patient-derived organoids and microfluidic devices. Aim 1 will define the changes in ExPAN- and IFAN-mediated activation of sympathetic neurons in the prevertebral ganglia (PVG) during active colon inflammation and after recovery. Aim 2 will determine the role of PVG sympathetic neurons for dysmotility and mucosal healing in colitis. The proposed research and training will significantly advance the applicant's expertise in cutting-edge techniques and technologies related to gut-brain signaling, while uncovering novel mechanisms that address a critical gap in our understanding of sympathetic regulation in colitis.

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESF32Fellowships in Digestive Diseases and Nutrition[DDK-F]sympatheticcolonapplicantneural pathwayscolitisgut-brainafferentrecovery

Questions for Mayo Clinic Rochester

Answered by the team behind this research.

Same institution, same topic, scored first.